They suggested that sulforaphane might delay the development of cervical cancer cells by arresting cell growth in the G2/M phase via the down-regulation of the cyclin B1 gene expression, dissociation of the cyclin B1/CDC2 complex, and the up-regulation of GADD45β proteins. The gene discussed is CCNB1; the disease is cervical carcinoma.